Market Access for Pharmaceutical Products – trends and challenges
Head of Modelling, Outcomes Research, Statistics and Epidemiology
Assessment group, Global Pricing and
F. Hoffmann-La Roche AG
Telephone: +41 61 688 94 86
Marlene Gyldmark joined Roche Global Headquarter in the Global Pricing and Market Access group November 2000.
Current job responsibility at Roche is as Head of Modelling, Outcomes Research, Statistics and Epidemiology (MORSE) – HTA group, within Global Pricing and Market Access. The MORSE group is responsible for payer and HTA evidence generation.
Previous work experience include e.g. Health Economic Manager at Pfizer Denmark; International Health Economic and Strategic Pricing Manager Novo Nordisk International, Denmark; lecturer in economics at Royal Danish University of Pharmacy, Copenhagen, Denmark; Research Scientist at DSI - Institute for Health Service Research and Development, where Marlene participated in a number of EU concerted action projects on e.g. willingness to pay, economics of intensive care, socio-economic costs of AIDS and the HARMET project on standardizing methods for economic evaluation. Additional work experience includes Health Economist in the Tanzanian Ministry of Health, Dar es Salaam, Tanzania.
Marlene holds an MA in Economics, University of Copenhagen, Denmark, and an MPhil in Health Economics, University of York, UK.
Said about Marlene Gyldmark
"Extremely knowledgeable. An expert on her field."
"Marlene is excellent – both in her level of knowledge and the way she facilitates discussion."
“I was very impressed by Marlene’s ability to facilitate complex knowledge to an understandable level.”
“Marlene is highly competent, engaged and could provide many examples from “real life” to substantiate the theories and models, which made me feel very comfortable about her professionalism.”